The financing news reported by the Venture Capital Channel and the early entrepreneurial projects in various fields we are focusing on.
On October 17th, the Venture Capital Daily will check it. The Venture Capital Daily includes the financing news reported by today’s “Venture Channel” and the early entrepreneurial projects in various fields we are focusing on, enjoy~
New Ventures
Marketing technology turning point is coming, five trends are pointing to growth|new winds
Financing News Reports
Update | Provide industrial internet security solutions, “Chang Yang Technology” completes tens of millions Yuan Pre-B round financing
Starting|The fitness boom promotes coaching industry innovation, fitness college “Black Gres” completed 50 million A round of financing
Project Name: 世格赛思
In one sentence: Minimally invasive medical device R&D and sales
It is reported that “Shigesaisi” was awarded the angelic round of 10 million yuan by the Australian Silver Angel Fund on October 17. The financing will be mainly used for product development, production, study and research cooperation, production equipment investment and product registration of “Seghs”.
Founded in 2017, “Siegels” is a research and development and sales company of minimally invasive medical devices, mainly engaged in research and development, manufacturing and sales of minimally invasive medical devices. Its main products include ultrasonic soft tissue cutting hemostasis system, abdominal puncture device, laparoscopic instrument, polymer absorbable hemostatic clip, stapler and so on. Minimally invasive medical devices can be used for minimally invasive surgery. Minimally invasive surgery is a combination of modern medical imaging systems such as thoracoscopic and laparoscopy combined with medical instruments. Compared with traditional surgical methods, it has the advantages of small wounds, light pain, less bleeding, quick recovery, and short hospitalization. Therefore, in recent years, the application range of minimally invasive surgery has gradually expanded, and the market space is huge.
The company’s senior management personnel are composed of clinical seniors in the medical device industry, local leading personnel in medical device research and development in Shenzhen, and overseas Chinese from Japan and the United States. They have rich clinical and technical research experience. At present, “Shigesaisi” has applied for more than 30 domestic and foreign patents, including more than 20 invention patents, 2 international invention patents, and 12 granted patents.